Literature DB >> 30266893

A Patient-Reported Outcome Instrument to Assess Symptom Burden and Predict Survival in Patients with Advanced Cancer: Flipping the Paradigm to Improve Timing of Palliative and End-of-Life Discussions and Reduce Unwanted Health Care Costs.

Stuart L Goldberg1,2, Dhakshila Paramanathan3, Raya Khoury4, Sharmi Patel4, Dayo Jagun4, Srikesh Arunajadai3, Victoria DeVincenzo3, Ruth Pe Benito3, Brooke Gruman3, Sukhi Kaur3, Scott Paddock3, Andrew D Norden3, Eric V Schultz3, John Hervey3, Terrill Jordan5, Andre Goy2, Andrew L Pecora3,6.   

Abstract

BACKGROUND: Discussions regarding palliative care and end-of-life care issues are frequently delayed past the time of usefulness, resulting in unwanted medical care. We sought to develop a patient-reported outcome (PRO) instrument that allows patients to voice their symptom burdens and facilitate timing of discussions. SUBJECTS, MATERIALS, AND METHODS: A seven-item PRO instrument (Cota Patient Assessed Symptom Score-7 item [CPASS-7]) covering physical performance status, pain, burden, and depression was administered (September 2015 through October 2016) with correlation to overall survival, correcting for time to complete survey since diagnosis.
RESULTS: A total of 1,191 patients completed CPASS-7 at a median of 560 days following the diagnosis of advanced cancer. Of these patients, 49% were concerned that they could not do the things they wanted; 35% reported decreased performance status. Financial toxicity was reported by 39% of patients, with family burdens noted in 25%. Although depression was reported by 15%, 43% reported lack of pleasure. Pain was reported by 33%. The median CPASS-7 total symptom burden score was 16 (possible 0-112). With a median follow-up of 15 months from initial survey, 46% had died. Patients with symptom burden scores <29 and ≥29 had a 6-month overall survival rate of 87% and 67%, respectively, and 12-month survival rates of 72% and 50%. A one-point score increase resulted in a 1.8% increase in expected hazard.
CONCLUSION: Patients with advanced cancer with higher levels of symptom burden, as self-reported on the CPASS-7, had inferior survival. The PRO facilitates identification of patients appropriate for reassessment of treatment goals and potentially palliative and end-of-life care in response to symptom burden concerns. IMPLICATIONS FOR PRACTICE: A seven-item patient-reported outcome (PRO) instrument was administered to 1,191 patients with advanced cancers. Patients self-reporting higher levels of physical and psychological symptom burden had inferior overall survival rates. High individual item symptom PRO responses should serve as a useful trigger to initiate supportive interventions, but when scores indicate global problems, discussions regarding end-of-life care might be appropriate. © AlphaMed Press 2018.

Entities:  

Keywords:  Hospice; Neoplasms; Palliative care; Patient‐reported outcome measures

Year:  2018        PMID: 30266893      PMCID: PMC6324621          DOI: 10.1634/theoncologist.2018-0238

Source DB:  PubMed          Journal:  Oncologist        ISSN: 1083-7159


  46 in total

1.  Trends in inpatient treatment intensity among Medicare beneficiaries at the end of life.

Authors:  Amber E Barnato; Mark B McClellan; Christopher R Kagay; Alan M Garber
Journal:  Health Serv Res       Date:  2004-04       Impact factor: 3.402

2.  Benchmarks for value in cancer care: an analysis of a large commercial population.

Authors:  Michael Kolodziej; J Russell Hoverman; Jody S Garey; Janet Espirito; Sheetal Sheth; Aimee Ginsburg; Marcus A Neubauer; Debra Patt; Barry Brooks; Charles White; Mark Sitarik; Roger Anderson; Roy Beveridge
Journal:  J Oncol Pract       Date:  2011-09       Impact factor: 3.840

3.  Early palliative care for patients with metastatic non-small-cell lung cancer.

Authors:  Jennifer S Temel; Joseph A Greer; Alona Muzikansky; Emily R Gallagher; Sonal Admane; Vicki A Jackson; Constance M Dahlin; Craig D Blinderman; Juliet Jacobsen; William F Pirl; J Andrew Billings; Thomas J Lynch
Journal:  N Engl J Med       Date:  2010-08-19       Impact factor: 91.245

4.  Patient preferences for communication with physicians about end-of-life decisions. SUPPORT Investigators. Study to Understand Prognoses and Preference for Outcomes and Risks of Treatment.

Authors:  J C Hofmann; N S Wenger; R B Davis; J Teno; A F Connors; N Desbiens; J Lynn; R S Phillips
Journal:  Ann Intern Med       Date:  1997-07-01       Impact factor: 25.391

5.  Quality of end-of-life care for patients with advanced cancer in an academic medical center.

Authors:  Sydney Morss Dy; Steven M Asch; Karl A Lorenz; Kristina Weeks; Rashmi K Sharma; Antonio C Wolff; Jennifer L Malin
Journal:  J Palliat Med       Date:  2011-03-10       Impact factor: 2.947

6.  End-of-Life Services Among Patients With Cancer: Evidence From Cancer Registry Records Linked With Commercial Health Insurance Claims.

Authors:  Cara L McDermott; Catherine Fedorenko; Karma Kreizenbeck; Qin Sun; Bruce Smith; J Randall Curtis; Ted Conklin; Scott D Ramsey
Journal:  J Oncol Pract       Date:  2017-07-19       Impact factor: 3.840

7.  Diagnostic accuracy of the palliative prognostic score in hospitalized patients with advanced cancer.

Authors:  Paul A Glare; Steffen Eychmueller; Patrick McMahon
Journal:  J Clin Oncol       Date:  2004-12-01       Impact factor: 44.544

Review 8.  Communication in end-stage cancer: review of the literature and future research.

Authors:  Elizabeth D Trice; Holly G Prigerson
Journal:  J Health Commun       Date:  2009

9.  Health care costs for patients with cancer at the end of life.

Authors:  Benjamin Chastek; Carolyn Harley; Joel Kallich; Lee Newcomer; Carly J Paoli; April H Teitelbaum
Journal:  J Oncol Pract       Date:  2012-07-03       Impact factor: 3.840

10.  Survival determinants in extensive-stage non-small-cell lung cancer: the Southwest Oncology Group experience.

Authors:  K S Albain; J J Crowley; M LeBlanc; R B Livingston
Journal:  J Clin Oncol       Date:  1991-09       Impact factor: 44.544

View more
  2 in total

1.  Medical Cannabis: Toward a New Policy and Health Model for an Ancient Medicine.

Authors:  Davide Fortin; Fabienne Marcellin; Patrizia Carrieri; Julien Mancini; Tangui Barré
Journal:  Front Public Health       Date:  2022-05-27

2.  Patient and clinician nudges to improve symptom management in advanced cancer using patient-generated health data: study protocol for the PROStep randomised controlled trial.

Authors:  Ravi B Parikh; William Ferrell; Jonathan Wakim; Joelle Williamson; Neda Khan; Michael Kopinsky; Mohan Balachandran; Peter E Gabriel; Yichen Zhang; Lynn M Schuchter; Lawrence N Shulman; Jinbo Chen; Mitesh S Patel; Christopher R Manz
Journal:  BMJ Open       Date:  2022-05-12       Impact factor: 3.006

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.